Juan Andres

Insider Reports History

Reporting-owner location: Cambridge, MA
Latest reporting-owner signature: /s/ Scott Baker, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Juan Andres

Form 4 holding Chief Technical Operations and Quality Officer

Moderna, Inc.

Security class: Common Stock
Shares / value: 12,803
Estimated value: $1,330,232
Report date: 28 Dec 2022
Price: $103.90
Ownership: Direct

Form 4 holding Director

Avantor, Inc.

Security class: Common Stock
Shares / value: 65,480
Estimated value: $996,605
Report date: 08 May 2025
Price: $15.22
Ownership: Direct

Form 4 holding Chief Technical Operations and Quality Officer

Moderna, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 203,025
Estimated value
Report date: 28 Dec 2022
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

Evelo Biosciences, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 20,000
Estimated value
Report date: 08 Jun 2023
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Juan Andres

4 AVTR

Avantor, Inc.

Report period: 08 May 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 May 2025, 17:33
Role: Director
Next action: Open filing details

4 AVTR

Avantor, Inc.

Report period: 09 May 2024
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 May 2024, 16:28
Role: Director
Next action: Open filing details

4

Evelo Biosciences, Inc.

Report period: 08 Jun 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Jun 2023, 16:03
Role: Director
Next action: Open filing details

4 AVTR

Avantor, Inc.

Report period: 11 May 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 May 2023, 16:44
Role: Director
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 28 Dec 2022
Transactions: 3
Transaction value: -$318,140
Accepted by SEC: 30 Dec 2022, 15:31
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 21 Dec 2022
Transactions: 3
Transaction value: -$361,540
Accepted by SEC: 23 Dec 2022, 16:00
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 14 Dec 2022
Transactions: 3
Transaction value: -$348,140
Accepted by SEC: 16 Dec 2022, 15:08
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 07 Dec 2022
Transactions: 3
Transaction value: -$302,460
Accepted by SEC: 09 Dec 2022, 15:52
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 30 Nov 2022
Transactions: 3
Transaction value: -$305,180
Accepted by SEC: 02 Dec 2022, 15:12
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 28 Nov 2022
Transactions: 3
Transaction value: -$141,475
Accepted by SEC: 30 Nov 2022, 15:10
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 23 Nov 2022
Transactions: 3
Transaction value: -$314,160
Accepted by SEC: 25 Nov 2022, 12:38
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 16 Nov 2022
Transactions: 3
Transaction value: -$326,640
Accepted by SEC: 18 Nov 2022, 15:29
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 09 Nov 2022
Transactions: 6
Transaction value: -$314,933
Accepted by SEC: 14 Nov 2022, 15:41
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 02 Nov 2022
Transactions: 3
Transaction value: -$266,540
Accepted by SEC: 04 Nov 2022, 16:12
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 28 Oct 2022
Transactions: 5
Transaction value: -$516,280
Accepted by SEC: 31 Oct 2022, 16:03
Role: Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 26 Aug 2022
Transactions: 3
Transaction value: -$113,947
Accepted by SEC: 30 Aug 2022, 16:08
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 17 Aug 2022
Transactions: 3
Transaction value: -$288,620
Accepted by SEC: 19 Aug 2022, 16:56
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 09 Aug 2022
Transactions: 6
Transaction value: -$341,747
Accepted by SEC: 11 Aug 2022, 16:57
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 03 Aug 2022
Transactions: 3
Transaction value: -$294,120
Accepted by SEC: 05 Aug 2022, 16:38
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 27 Jul 2022
Transactions: 3
Transaction value: -$280,140
Accepted by SEC: 29 Jul 2022, 16:47
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 20 Jul 2022
Transactions: 3
Transaction value: -$292,140
Accepted by SEC: 22 Jul 2022, 16:40
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 13 Jul 2022
Transactions: 3
Transaction value: -$295,900
Accepted by SEC: 15 Jul 2022, 16:32
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 06 Jul 2022
Transactions: 3
Transaction value: -$267,840
Accepted by SEC: 08 Jul 2022, 16:04
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 01 Jul 2022
Transactions: 7
Transaction value: -$774,420
Accepted by SEC: 05 Jul 2022, 16:59
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4

Evelo Biosciences, Inc.

Report period: 09 Jun 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 13 Jun 2022, 16:35
Role: Director
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 08 Jun 2022
Transactions: 13
Transaction value: -$1,294,921
Accepted by SEC: 10 Jun 2022, 16:08
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 27 May 2022
Transactions: 3
Transaction value: +$136,486
Accepted by SEC: 01 Jun 2022, 17:17
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 AVTR

Avantor, Inc.

Report period: 12 May 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 16 May 2022, 18:14
Role: Director
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 09 May 2022
Transactions: 3
Transaction value: +$32,390
Accepted by SEC: 11 May 2022, 16:24
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 04 May 2022
Transactions: 3
Transaction value: -$278,020
Accepted by SEC: 06 May 2022, 16:06
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 29 Apr 2022
Transactions: 3
Transaction value: -$271,560
Accepted by SEC: 02 May 2022, 16:24
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 20 Apr 2022
Transactions: 3
Transaction value: -$277,560
Accepted by SEC: 22 Apr 2022, 16:08
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 13 Apr 2022
Transactions: 3
Transaction value: -$288,300
Accepted by SEC: 15 Apr 2022, 15:09
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 06 Apr 2022
Transactions: 3
Transaction value: -$286,560
Accepted by SEC: 08 Apr 2022, 16:06
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 AVTR

Avantor, Inc.

Report period: 01 Apr 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 05 Apr 2022, 17:00
Role: Director
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 30 Mar 2022
Transactions: 3
Transaction value: -$337,140
Accepted by SEC: 01 Apr 2022, 16:06
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 23 Mar 2022
Transactions: 3
Transaction value: -$340,880
Accepted by SEC: 25 Mar 2022, 16:13
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 16 Mar 2022
Transactions: 3
Transaction value: -$271,580
Accepted by SEC: 18 Mar 2022, 16:09
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 14 Mar 2022
Transactions: 3
Transaction value: -$271,560
Accepted by SEC: 15 Mar 2022, 16:19
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 01 Mar 2022
Transactions: 5
Transaction value: -$271,560
Accepted by SEC: 03 Mar 2022, 15:53
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 28 Feb 2022
Transactions: 3
Transaction value: -$970,822
Accepted by SEC: 02 Mar 2022, 15:27
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 24 Feb 2022
Transactions: 3
Transaction value: -$271,560
Accepted by SEC: 25 Feb 2022, 15:35
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 16 Feb 2022
Transactions: 3
Transaction value: -$271,560
Accepted by SEC: 18 Feb 2022, 15:34
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 09 Feb 2022
Transactions: 6
Transaction value: -$402,109
Accepted by SEC: 11 Feb 2022, 15:53
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 02 Feb 2022
Transactions: 3
Transaction value: -$313,340
Accepted by SEC: 04 Feb 2022, 15:06
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 31 Dec 2021
Transactions: 3
Transaction value: -$1,188,350
Accepted by SEC: 04 Jan 2022, 15:10
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 29 Dec 2021
Transactions: 3
Transaction value: -$1,138,950
Accepted by SEC: 30 Dec 2021, 16:03
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 27 Dec 2021
Transactions: 5
Transaction value: -$2,308,900
Accepted by SEC: 29 Dec 2021, 15:52
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 22 Dec 2021
Transactions: 3
Transaction value: -$1,260,250
Accepted by SEC: 23 Dec 2021, 15:11
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 17 Dec 2021
Transactions: 8
Transaction value: -$5,928,650
Accepted by SEC: 21 Dec 2021, 15:06
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 15 Dec 2021
Transactions: 3
Transaction value: -$1,299,500
Accepted by SEC: 17 Dec 2021, 15:25
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 10 Dec 2021
Transactions: 6
Transaction value: -$2,337,950
Accepted by SEC: 14 Dec 2021, 15:09
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 08 Dec 2021
Transactions: 3
Transaction value: -$1,350,700
Accepted by SEC: 10 Dec 2021, 15:08
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 03 Dec 2021
Transactions: 8
Transaction value: -$5,536,700
Accepted by SEC: 07 Dec 2021, 15:07
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 01 Dec 2021
Transactions: 3
Transaction value: -$1,588,500
Accepted by SEC: 03 Dec 2021, 16:04
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 26 Nov 2021
Transactions: 6
Transaction value: -$3,327,900
Accepted by SEC: 30 Nov 2021, 15:09
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 24 Nov 2021
Transactions: 3
Transaction value: -$1,304,000
Accepted by SEC: 26 Nov 2021, 13:08
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 19 Nov 2021
Transactions: 8
Transaction value: -$5,086,950
Accepted by SEC: 23 Nov 2021, 17:16
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 17 Nov 2021
Transactions: 3
Transaction value: -$1,111,800
Accepted by SEC: 19 Nov 2021, 15:15
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 12 Nov 2021
Transactions: 6
Transaction value: -$2,162,250
Accepted by SEC: 16 Nov 2021, 15:23
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 10 Nov 2021
Transactions: 3
Transaction value: -$1,088,950
Accepted by SEC: 12 Nov 2021, 15:16
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 05 Nov 2021
Transactions: 8
Transaction value: -$4,432,650
Accepted by SEC: 09 Nov 2021, 15:36
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 03 Nov 2021
Transactions: 3
Transaction value: -$1,688,950
Accepted by SEC: 05 Nov 2021, 17:09
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 29 Oct 2021
Transactions: 6
Transaction value: -$3,275,350
Accepted by SEC: 02 Nov 2021, 16:16
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 27 Oct 2021
Transactions: 3
Transaction value: -$1,660,200
Accepted by SEC: 29 Oct 2021, 16:32
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 22 Oct 2021
Transactions: 10
Transaction value: -$6,330,842
Accepted by SEC: 26 Oct 2021, 17:13
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 20 Oct 2021
Transactions: 3
Transaction value: -$1,608,450
Accepted by SEC: 22 Oct 2021, 17:39
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 15 Oct 2021
Transactions: 6
Transaction value: -$3,195,450
Accepted by SEC: 19 Oct 2021, 16:11
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 13 Oct 2021
Transactions: 3
Transaction value: -$1,513,450
Accepted by SEC: 14 Oct 2021, 16:21
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 08 Oct 2021
Transactions: 8
Transaction value: -$5,808,000
Accepted by SEC: 12 Oct 2021, 16:16
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 06 Oct 2021
Transactions: 3
Transaction value: -$1,530,100
Accepted by SEC: 08 Oct 2021, 16:18
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 01 Oct 2021
Transactions: 6
Transaction value: -$3,210,600
Accepted by SEC: 05 Oct 2021, 16:12
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 29 Sep 2021
Transactions: 3
Transaction value: -$1,906,150
Accepted by SEC: 01 Oct 2021, 08:53
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 24 Sep 2021
Transactions: 8
Transaction value: -$8,436,700
Accepted by SEC: 28 Sep 2021, 16:22
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 22 Sep 2021
Transactions: 3
Transaction value: -$2,103,950
Accepted by SEC: 24 Sep 2021, 16:09
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 17 Sep 2021
Transactions: 6
Transaction value: -$4,157,200
Accepted by SEC: 21 Sep 2021, 16:17
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 15 Sep 2021
Transactions: 3
Transaction value: -$2,074,600
Accepted by SEC: 17 Sep 2021, 17:26
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 10 Sep 2021
Transactions: 8
Transaction value: -$8,776,200
Accepted by SEC: 14 Sep 2021, 16:20
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 07 Sep 2021
Transactions: 6
Transaction value: -$4,094,450
Accepted by SEC: 09 Sep 2021, 16:23
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 03 Sep 2021
Transactions: 3
Transaction value: -$1,900,700
Accepted by SEC: 07 Sep 2021, 16:24
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 01 Sep 2021
Transactions: 3
Transaction value: -$1,848,050
Accepted by SEC: 03 Sep 2021, 08:56
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 27 Aug 2021
Transactions: 8
Transaction value: -$7,280,350
Accepted by SEC: 31 Aug 2021, 16:49
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 25 Aug 2021
Transactions: 3
Transaction value: -$1,896,900
Accepted by SEC: 27 Aug 2021, 16:40
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 20 Aug 2021
Transactions: 6
Transaction value: -$3,702,850
Accepted by SEC: 24 Aug 2021, 16:29
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 18 Aug 2021
Transactions: 3
Transaction value: -$1,973,950
Accepted by SEC: 20 Aug 2021, 09:17
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 16 Aug 2021
Transactions: 5
Transaction value: -$5,505,900
Accepted by SEC: 18 Aug 2021, 16:48
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 13 Aug 2021
Transactions: 3
Transaction value: -$1,963,950
Accepted by SEC: 16 Aug 2021, 16:58
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 11 Aug 2021
Transactions: 3
Transaction value: -$2,155,650
Accepted by SEC: 13 Aug 2021, 16:10
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 06 Aug 2021
Transactions: 6
Transaction value: -$3,986,900
Accepted by SEC: 10 Aug 2021, 16:18
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 04 Aug 2021
Transactions: 3
Transaction value: -$1,863,200
Accepted by SEC: 06 Aug 2021, 09:05
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 30 Jul 2021
Transactions: 8
Transaction value: -$6,892,550
Accepted by SEC: 03 Aug 2021, 16:23
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 28 Jul 2021
Transactions: 3
Transaction value: -$1,603,550
Accepted by SEC: 30 Jul 2021, 16:28
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 23 Jul 2021
Transactions: 6
Transaction value: -$3,292,350
Accepted by SEC: 27 Jul 2021, 17:29
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 21 Jul 2021
Transactions: 3
Transaction value: -$1,433,950
Accepted by SEC: 23 Jul 2021, 09:28
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 16 Jul 2021
Transactions: 8
Transaction value: -$5,404,350
Accepted by SEC: 20 Jul 2021, 16:15
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 14 Jul 2021
Transactions: 3
Transaction value: -$1,125,050
Accepted by SEC: 16 Jul 2021, 09:26
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 12 Jul 2021
Transactions: 3
Transaction value: -$1,092,500
Accepted by SEC: 14 Jul 2021, 16:23
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 07 Jul 2021
Transactions: 3
Transaction value: -$1,097,750
Accepted by SEC: 09 Jul 2021, 16:36
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 06 Jul 2021
Transactions: 3
Transaction value: -$1,087,050
Accepted by SEC: 08 Jul 2021, 08:17
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 30 Jun 2021
Transactions: 3
Transaction value: -$1,123,950
Accepted by SEC: 02 Jul 2021, 16:33
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 28 Jun 2021
Transactions: 3
Transaction value: -$1,053,950
Accepted by SEC: 30 Jun 2021, 16:39
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 23 Jun 2021
Transactions: 3
Transaction value: -$1,037,200
Accepted by SEC: 25 Jun 2021, 17:26
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 21 Jun 2021
Transactions: 3
Transaction value: -$943,250
Accepted by SEC: 23 Jun 2021, 16:47
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 16 Jun 2021
Transactions: 3
Transaction value: -$938,950
Accepted by SEC: 21 Jun 2021, 18:58
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 14 Jun 2021
Transactions: 3
Transaction value: -$1,005,550
Accepted by SEC: 15 Jun 2021, 16:24
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 09 Jun 2021
Transactions: 3
Transaction value: -$1,000,450
Accepted by SEC: 11 Jun 2021, 16:11
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4

Evelo Biosciences, Inc.

Report period: 08 Jun 2021
Transactions: 2
Transaction value: $0
Accepted by SEC: 11 Jun 2021, 16:04
Role: Director
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 07 Jun 2021
Transactions: 3
Transaction value: -$974,150
Accepted by SEC: 09 Jun 2021, 16:14
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 01 Jun 2021
Transactions: 6
Transaction value: -$1,717,800
Accepted by SEC: 03 Jun 2021, 16:43
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 26 May 2021
Transactions: 3
Transaction value: -$782,450
Accepted by SEC: 27 May 2021, 16:08
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 24 May 2021
Transactions: 3
Transaction value: -$751,200
Accepted by SEC: 25 May 2021, 16:32
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 19 May 2021
Transactions: 3
Transaction value: -$717,650
Accepted by SEC: 20 May 2021, 17:10
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 17 May 2021
Transactions: 3
Transaction value: -$735,100
Accepted by SEC: 18 May 2021, 16:21
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 12 May 2021
Transactions: 3
Transaction value: -$709,500
Accepted by SEC: 13 May 2021, 16:10
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

4 MRNA

Moderna, Inc.

Report period: 10 May 2021
Transactions: 3
Transaction value: -$760,850
Accepted by SEC: 11 May 2021, 16:10
Role: Chief Technical Operations and Quality Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .